Adiponectin levels and atherosclerotic risk factors in pediatric chronic peritoneal dialysis patients

Sevcan A Bakkaloglu1, Necla Buyan, Tohru Funahashi

  • 1Department of Pediatric Nephrology, Gazi University, Ankara, Turkey. sevcan@gazi.edu.tr

Insights

In pediatric patients on chronic peritoneal dialysis (CPD), serum adiponectin (ADPN) levels were inversely associated with creatinine. This suggests ADPN may be a novel prognostic marker for cardiovascular risk in these children.

Area of Science:

  • Pediatric Nephrology
  • Cardiovascular Risk Assessment
  • Renal Disease Biomarkers

Background:

  • Atherosclerotic vascular diseases are a leading cause of mortality in pediatric end-stage renal disease (ESRD) patients undergoing chronic peritoneal dialysis (CPD).
  • Adiponectin (ADPN), an anti-atherogenic protein, is elevated in ESRD, but low levels are linked to cardiovascular death.
  • The role of ADPN in pediatric CPD patients requires further clarification.

Purpose of the Study:

  • To investigate atherosclerotic risk factors in children on CPD.
  • To determine the significance of serum adiponectin (ADPN) levels in pediatric CPD patients.

Main Methods:

  • A cross-sectional study was conducted in a university hospital's pediatric peritoneal dialysis unit.
  • 18 children on CPD and 20 healthy controls were assessed for serum ADPN, blood pressure, glucose, lipids, apolipoprotein B, C-reactive protein (CRP), lipoprotein(a), and homocysteine.
  • Statistical analysis correlated ADPN levels with clinical parameters.

Main Results:

  • Serum ADPN levels were significantly higher (threefold) in pediatric CPD patients compared to controls.
  • Apolipoprotein B and CRP levels were also elevated in the CPD group.
  • A significant negative correlation was observed between log ADPN and creatinine levels (r = -0.54, p < 0.05) in CPD patients.

Conclusions:

  • Serum ADPN levels are inversely associated with creatinine in pediatric CPD patients.
  • ADPN may serve as a novel predictive marker for prognosis in pediatric patients with ESRD on CPD.
  • Further research is warranted to validate ADPN as a biomarker for cardiovascular risk in this population.
Abstract

Related Concept Videos

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Peritoneal Dialysis III: Nursing Management01:25

Peritoneal Dialysis III: Nursing Management

Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...